Skip to main content

Table 1 Clinical characteristics of studied patients

From: Characteristics of COVID and post COVID polyneuropathies in adults and pediatrics: an Egyptian sample

  Frequency
Neuropathy AIDP (motor and sensory) 25 (59.5%)
  AMSAN 8 (19%)
  Demyelinating with secondary axonal 5 (11.9%)
  CIDP like 4 (9.5%)
CT chest Normal 2 (4.8%)
Interstitial pneumonia 3 (7.1%)
Interstitial pneumonia without parenchymal opacity 4 (9.5%)
Bilateral GGO 33 (78.6%)
PCR Positive 36 (85.7%)
CBC Lymphopenia 30 (71.4%)
CRP Elevated 31 (73.8%)
Outcome Full Improvement 31 (73.8)
No improvement and needed second treatment to improve 8 (19%)
Minimal improvement 3 (7.1%)
  Total 42 (100%)
  1. AIDP acute inflammatory demyelinating polyneuropathy, AMSAN acute motor sensory axonal neuropathy, CIDP chronic inflammatory demyelinating polyneuropathy, CT computed tomography, GGO ground glass opacity, CBC complete blood count, CRP C reactive protein